Conforms and improves the process for determining incapacity.
This bill revises New York’s rules for determining when a person lacks capacity to make health care decisions, with a focus on health care proxies, surrogate decision-making, and orders involving life-sustaining treatment. It amends the Public Health Law and the Surrogate’s Court Procedure Act to standardize terminology, clarify who may make initial and concurring incapacity determinations, and require that those determinations be made in writing and documented in the patient’s medical record. The bill also bars a practitioner who has been appointed as a patient’s agent from making the capacity determination for that patient.
For decisions to withdraw or withhold life-sustaining treatment, the bill preserves the requirement for a concurring determination but refines who may provide it and under what circumstances. It specifies qualifications for practitioners involved when incapacity is based on mental illness, developmental disability, or intellectual disability, and it updates rules for hospital, hospice, residential health care facility, correctional facility, and home care settings. The bill also limits the role of ethics review committees to nonhospital orders issued in a hospital or hospice, and makes conforming changes to provisions governing health care proxy authority and surrogate consent.
The bill would amend multiple sections of the Public Health Law and the Surrogate’s Court Procedure Act, primarily sections governing health care proxies, surrogate decision-making, nonhospital orders not to resuscitate, and incapacity determinations for persons with developmental or intellectual disabilities. It shifts language from physician-centered determinations to broader references to attending practitioners and health or social services practitioners, while preserving specialized qualification requirements in certain cases. The bill would affect hospitals, hospices, residential health care facilities, correctional facilities, home care agencies, practitioners, ethics review committees, patients, agents under health care proxies, and surrogates making end-of-life decisions.
The bill appears generally procedural and technical in nature, aimed at conforming and clarifying existing incapacity-determination law rather than creating a new policy direction. Based on the bill text and the absence of recorded committee debate or votes in the provided materials, there is no visible evidence of organized opposition or support in the record here. The overall tone of the legislation suggests an effort to improve consistency, documentation, and clarity in medical decision-making processes.
The main points of potential contention are the bill’s changes to who may determine incapacity and who may provide the required concurring determination, especially in life-sustaining treatment cases. Stakeholders concerned with patient safeguards may focus on whether broadening the pool of qualified practitioners preserves adequate protections, while health care providers may focus on whether the revised rules reduce confusion and administrative burden. Additional sensitivity may arise around determinations based on mental illness, developmental disability, or intellectual disability, where the bill retains specialized qualifications and consultation requirements to address concerns about expertise and reliability.